Business & Scientific Resources

Your Company's Response to Coronavirus

As cases of coronavirus (COVID-19) continue to increase around the world, this resource center is designed to keep you informed on key information to keep your employees safe and business operating. This information will be regularly updated, check back often.

  • Show All
As part of the Business Loan Task Force, Arent Fox has summarized the "Paycheck Protection Program” (PPP) for small businesses.
Arent Fox LLP offers guidance on the EEOC publication "What You Should Know about the ADA, the Rehabilitation Act, and COVID-19."
With COVID-19 creating a shortage of critical medical supplies, such as swabs for diagnostic tests, personal protective equipment (PPE), and ventilators, owners of 3D printers around the world—from leading industrial manufacturers to individual makers—are mobilizing to fill the gap.
Arnold & Porter has issued guidance on the HHS General Counsel's advisory opinion that addresses questions and concerns about the scope of immunity during the COVID-19 pandemic pursuant to the Public Readiness and Emergency Preparedness Act (PREP Act). 
Arnold & Porter has provided an overview of the HHS June Amendment to the March 10, 2020 Public Readiness and Emergency Preparedness Act (PREP Act) Declaration for medical countermeasures against COVID-19 (COVID-19 Declaration). 
Arnold & Porter has provided an overview of the FDA guidance issued on the new medical device shortage reporting requirements.
The U.S. Chamber of Commerce has developed an interactive map that shows how aid available under the Small Business Paycheck Protection Program, created as part of the (CARES) Act, could help the small businesses in each state.
The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks.
BARDA is temporarily suspending AOIs 1-3 as part of its EZ-BAA (BAA-20-100-SOL-0002) but is now accepting abstract submissions for AOI #4: 2019-nCoV.
BARDA added new topics under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
BIO's Draft Return to Office Policy is attached to be used as an example document for companies considering return to office plans. 
BIO has attached example guidelines for department heads as companies develop return to office plans.   
Last update: Monday, January 25, 2021 @ 4:42 pm EST